TCL Archive In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced August 3, 1990
TCL Archive ASCO Annual Report Names Significant Clinical Research Advances Of Past Year December 25, 2009
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
